It is important to also choose a provider that is able to support the patient with access to a pharmacist and advice throughout the treatment
p 40% to meet its primary endpoint, addressing a prominent and longstanding therapeutic challenge, since HFpEF constitutes about half of patients with chronic HF and historically has lacked therapies that modify cardiovascular outcomes
Dihexa, a synthetic mimetic of Angiotensin IV, is a peptide of particular interest in neuroscience, studied for its potent neurogenic and synaptogenic capabilities
Dosing, duration, monitoring, and adjustment guidelines
A treatment course followed by appropriate washout can be an effective pre-conception strategy when planned with a healthcare provider
Maintenance dose: 0.75 to 1.5 mg subcutaneously once a week